Peter G. Traber - Sep 25, 2023 Form 4 Insider Report for SELECTA BIOSCIENCES INC (SELB)

Role
Chief Medical Officer
Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Peter G. Traber
Stock symbol
SELB
Transactions as of
Sep 25, 2023
Transactions value $
-$747
Form type
4
Date filed
9/26/2023, 06:00 PM
Previous filing
Jan 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction SELB Common Stock Sale -$747 -705 -0.16% $1.06 452K Sep 25, 2023 Direct F1, F2

Explanation of Responses:

Id Content
F1 Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.
F2 Includes 6,410 shares of common stock purchased under the Issuer's Employee Stock Purchase Program during the contribution period between September 1, 2022 and February 28, 2023.